AI Can Select Molecules, but Has Yet to Prove It Can Create Better Drugs: Pharmaceutical Evaluation Must Move Beyond Leaderboards
A perspective article in Nature Reviews Drug Discovery notes that improvements in model accuracy have yet to translate into clear clinical benefits; the next generation of evaluations should ask whether AI truly improves R&D decision-making.